AstraZeneca Plc got a rare sell rating on Thursday as Deutsche Bank AG analysts downgraded the British drugmaker, taking a more skeptical view on the company’s drug pipeline, in particular for breast cancer treatments.
Source link
AstraZeneca Gets Rare Sell as Deutsche Bank Has Pipeline Worries
Byutsavmoradiya12@gmail.com
Oct 16, 2025